PFE240719C28000
- 1.52
- +0.30+24.59%
Pfizer Newsroom
Pfizer Options Spot-On: On July 16th, 125.33K Contracts Were Traded, With 2.91 Million Open Interest
On July 16th ET, $Pfizer(PFE.US)$ had active options trading, with a total trading volume of 125.33K options for the day, of which put options accounted for 23.31% of the total transactions, and
Pfizer (NYSE:PFE) Takes On Some Risk With Its Use Of Debt
3 Compelling Reasons to Own Pfizer (NYSE:PFE) Stock
Analysts' Opinions Are Mixed on These Healthcare Stocks: KalVista Pharmaceuticals (KALV), Roche Holding AG (OtherRHHVF) and Pfizer (PFE)
Pfizer (PFE) Exceeds Market Returns: Some Facts to Consider
Pfizer Options Spot-On: On July 15th, 127.16K Contracts Were Traded, With 2.92 Million Open Interest
On July 15th ET, $Pfizer(PFE.US)$ had active options trading, with a total trading volume of 127.16K options for the day, of which put options accounted for 39.0% of the total transactions, and call
Wall Street's Most Accurate Analysts Say Buy These 3 Health Care Stocks With Over 3% Dividend Yields
During times of turbulence and uncertainty in the markets, even when markets are at all-time highs, many investors turn to dividend-yielding stocks. These are often companies that have high free
Decoding Pfizer's Options Activity: What's the Big Picture?
Investors with a lot of money to spend have taken a bullish stance on Pfizer (NYSE:PFE).And retail traders should know.We noticed this today when the trades showed up on publicly available options
Pfizer Stock (NYSE:PFE): Super Cheap, 5.7% Yield, Potential Weight Loss Catalyst
Pfizer stock has been struggling, but looking among the market’s laggards can yield attractive opportunities. The stock is super cheap, sports a stellar 5.7% dividend yield and has an interesting potential catalyst on deck in the form of a new weight loss drug candidate that it is moving forward on developing.
Unusual Options Activity: GPS, VLO and Others Attract Market Bets, GPS V/OI Ratio Reaches 37.9
EST Jul 15th Morning Delivery - In the last two hours of trading, 10 options with a high V/OI ratio were detected. With the market volatile, it's crucial to stay informed on the latest options trends.
Here Is What to Know Beyond Why Pfizer Inc. (PFE) Is a Trending Stock
Viiv Healthcare To Announce Data From Randomised Clinical Trial For 2-Drug Regimen Dovato Against 3-Drug Regimen Biktarvy At AIDs 2024
Findings from the SEIMC-GeSIDA Foundation (FSG) PASO-DOBLE study will include treatment efficacy, safety, and weight gain experienced by participants taking Dovato (dolutegravir/lamivudine) or
Morgan Stanley Sees $180B Patent Cliff, $380B Deal Capacity Fueling Biopharma M&A
Goldman Sachs Maintains Pfizer(PFE.US) With Buy Rating, Maintains Target Price $31
Goldman Sachs analyst Chris Shibutani maintains $Pfizer(PFE.US)$ with a buy rating, and maintains the target price at $31.According to TipRanks data, the analyst has a success rate of 44.9% and a
Inflation Drop Fuels Rate Cut Speculation, Investors Shift To Sector Laggards, Russell 2000 Surges Over 3.6%: This Week In The Markets
Consumer price index data this week provided encouraging signs that American inflation is moving ever closer to the Federal Reserve's much-discussed 2% target.This fueled speculation about interest
Pfizer Options Spot-On: On July 12th, 180.09K Contracts Were Traded, With 2.9 Million Open Interest
On July 12th ET, $Pfizer(PFE.US)$ had active options trading, with a total trading volume of 180.09K options for the day, of which put options accounted for 33.57% of the total transactions, and
Unusual Options Activity: RDDT, GXO and Others Attract Market Bets, RDDT V/OI Ratio Reaches 200.2
EST Jul 12th Closing Delivery - In the last three hours of trading, 10 options with a high V/OI ratio were detected. With the market volatile, it's crucial to stay informed on the latest options
What the 2000's Tech Bubble Says About Today's Suspected Rotation - Analyst
With Oral Anti-Obesity Candidate Development, Pfizer Seeks Relevant And Competitive Presence - Goldman Sachs
Thursday, Pfizer Inc (NYSE:PFE) announced it selected its preferred once-daily modified release formulation for danuglipron, an oral glucagon-like peptide-1 (GLP-1) receptor agonist.
PFE or NVO: Which Is the Better Value Stock Right Now?
Investors interested in stocks from the Large Cap Pharmaceuticals sector have probably already heard of Pfizer (PFE) and Novo Nordisk (NVO).